The role of palmaz stent-grafts in evar  by McManus, Claire et al.
Abstracts / International Journal of Surgery 11 (2013) 686e745 737
ABSTRACTS0544: THE USE OF HUMAN CADAVERS AND VIRTUAL REALITY SIMULA-
TION IN ENDOVASCULAR TRAINING: A QUESTIONNAIRE OF PATIENT
AND PROFESSIONAL OPINION
Stuart Maitland 1, Craig Nesbitt 1, Roger Searle 2, Gerard Stansby 1. 1 Freeman
Hospital, NUT, Newcastle Upon Tyne, UK; 2Newcastle University, NUT,
Newcastle Upon Tyne, UK.
Aim: To establish the opinion of patients and clinicians on the use of vir-
tual reality simulators (VRS) and human cadavers (HC) for endovascular
training.
Methods: Experts in interventional cardiology, radiology and vascular
surgery rated their agreement to statements regarding endovascular
simulation (HC and VRS) through an online questionnaire. Patients' views
on endovascular simulation training were also sought.
Results: 100 professionals completed questionnaires. < 25% were aware
of endovascular HC training, none had ﬁrst hand experience, ﬁve (5.6%)
disagreed with its use. All candidates were aware of VRS, 80.9% had ﬁrst
hand experience. Many expressed interest in HC stating concerns
regarding the realism of VRS. 107 patients (50 non-vascular, 57
vascular*) responded. All patients agreed with HC training. Patients
declared greater conﬁdence in doctors trained on HC versus VRS
(p¼0.000).
Conclusion: These are the ﬁrst recorded opinions of professionals and
patients regarding endovascular simulation training. Endovascular pro-
fessionals question the suitability, appropriateness and feasibility of
endovascular HC training, yet few are wholly satisﬁed with VRS. Patients
appreciate the need for adjunctive simulation training, but harbor mistrust
in computer technology. Enhanced patient education is required to
maintain conﬁdence and trust.
* non-vascular patients have no history of vascular disease
0547: TYPE II ENDOLEAKS: LOW RISK OF RUPTURE AND HIGH RISK OF
TREATMENT FAILURE
David Sidloff, Philip Stather, Eddie Choke, Matt Bown, Robert Sayers.
University of Leicester, Leicester, UK.
Aim: To assess the risk of rupture and determine the beneﬁts of inter-
vention for the treatment of type II endoleaks after endovascular
abdominal aortic aneurysm repair.
Method: A systematic review was performed according to PRISMA
guidelines. Outcome data including incidence, spontaneous resolution,
sac expansion, interventions, success, and complications were recorded.
Results: 32 non-randomised retrospective studies were included, totalling
21,728 patients, 1515 type II endoleaks and 392 interventions. This analysis
reveals type II endoleaks have an incidence of 10% with 32.3% spontane-
ously resolving. 14 ruptures were reported (incidence 0.9%), from which
43% did not have concurrent sac expansion. Analysing interventions, 28%
were unsuccessful. Translumbar embolization had a higher success rate
compared to transarterial embolization (TL81% v TA62.5% P¼0.024) with
fewer persistent endoleaks (TA36% Vs TL19% P¼0.0396). Transarterial
embolizations had a higher associated number of complications (TA10% Vs
TL0% P¼0.0426).
Conclusion: This review has revealed that rupture secondary to an iso-
lated type II endoleak is rare (<1%) and that over a third occur in the
absence of sac expansion. Nearly a third of all interventions for the treat-
ment of type II endoleaks fail, however a translumbar intervention has a
higher success rate with a lower risk of complications.
0555: AN EVALUATION OF OUR EARLY EXPERIENCE OF PERCUTANEOUS
EVAR USING THE PROSTAR XL DEVICE
David Ormesher, Jenna Godfrey, Andrew Schiro, David Murray,
Ferdinand Serracino-Inglott. Department of Vascular and Endovascular
Surgery, Manchester Royal Inﬁrmary, Manchester, UK.
Introduction: There is a trend towards less invasive procedures in all areas
of surgery. It is suggested that the use of percutaneous closure devices for
endovascular procedures that require larger seat sizes may have a positive
impact on patient outcomes.
Methods: A retrospective review of our endovascular logbook was un-
dertaken from which all patients who received a Prostar XL device were
identiﬁed and data collected.
Results: 96 Prostar XL devices were deployed. Mean skin to common
femoral artery (CFA) depth was 31.3mm, all but 5 patients had somedegree of CFA calciﬁcation. The median length of stay was 4 days. 4 pa-
tients went on to develop groin haematomas postoperatively; all of these
were treated conservatively. The Prostar XL cut through the CFA in one
patient and this required repair. 80% of complications were in the ﬁrst 15
cases.
Conclusion: No long-term complications in our series can be attributed to
the percutaneous approach for EVAR. We believe that US-guided puncture
can overcome problems associated with CFA calciﬁcation and that the
depth from skin to CFA has no impact on morbidity. The use of low proﬁle
devices (16F) and operator experience have a positive impact on out-
comes with the Prostar XL device.
0564: TEMPORAL ARTERY BIOPSY e TOO MANY TOO LATE?
Ruth Graham, Lourdusamy Selvam. West Wales General Hospital,
Carmarthen, UK.
Aim: To show Temporal artery biopsy(TAB) rarely inﬂuences patient
management, and that we should use the American College of Rheuma-
tologists (ACR) criteria (Score  3 sensitivity 93.5%, speciﬁcity 91.2%) to
identify which patients require biopsy to diagnose Temporal Arteritis(TA).
Methods: All patients who underwent a TAB at our institution (01/01/
2008-31/12/2011) were identiﬁed using histopathology records. Patient
case notes, histopathology and haematology records were reviewed to
determine the dates of diagnosis, biopsy and corticosteroid therapy and
the initial ACR score.
Results: Of the forty-three patients identiﬁed full data was available on
thirty-seven (13M:24F). The average age was sixty-eight (range 26-79). At
presentation thirty-ﬁve patients were over 50, eighteen had an ESR >50,
twenty-one had temporal tenderness and twenty a localised headache
meaning nineteen (51%) patients had an initial ACR score 3. Prior to bi-
opsy 70% (27) had corticosteroids. The average time from diagnosis to
biopsy was thirty-one days. There were only two positive biopsies (initial
ACR score was 3 in both cases).
Conclusions: TAB has a place in the diagnosis of TA but rarely inﬂuences
patient management. The ACR score should be used to diagnose and
initiate treatment in temporal arteritis. If biopsies are required a fast-track
surgical referral is recommended.
0569: RESULTS OF SIX YEARS OF ENDOVENOUS LASER ABLATION
(EVLA) FOR THE TREATMENT OF RECURRENT VARICOSE VEINS
Andrew McAvoy, Jade Myers, Rhodri Jenkins, Mandy Taylor, Frank Mason.
Southport District General Hospital, Southport, UK.
Varicose vein (VV) recurrence occurs in up to 20% of patients following
open surgery. ‘Re-do' VV surgery is technically challenging and compli-
cation rates approach 40%.
Aim: Our aim was to examine the recurrence and complication rate of
patients undergoing EVLA as a treatment for recurrent VV following pre-
vious surgery at a District General Hospital.
Methods: We included all patients since 2006 who underwent EVLA for
recurrent VV following previous surgery. We examined recurrence rates
and complications following this procedure.
Results: There were 80 EVLA procedures performed for VV recurrence
following previous surgery over the 6 year period. The complication rates
amongst this group of patients is shown below. Wound infection: 0%,
Altered sensation: 6%, Deep Vein Thrombosis: 0%, Phlebitis: 4%, Bleeding:
0%, Overall: 10%.
Post-treatment duplex scanning was performed in 32 patients. 75% of
patients had no residual reﬂux in the treated vein.
Conclusions: The overall complication rate following EVLA as a ‘re-do'
treatment for VV was 10%. Early recurrence rates are 25%. EVLA has a low
complication and recurrence rate when compared to ‘re-do' surgery.
0589: THE ROLE OF PALMAZ STENT-GRAFTS IN EVAR
Claire McManus, Stephen Badger, Julie Reid. Royal Victoria Hospital, Belfast,
Northern Ireland, UK.
Background: Palmaz stenting helps proximal ﬁxation in unfavourable
aneurysm necks. The study aimed to evaluate complications associated
with Palmaz stent-grafts.
Methods: Patients undergoing elective or emergency EVAR repair using a
Palmaz stent-graft between January 2001 and December 2011 were
reviewed. Morphological aneurysm changes were prospectively recorded
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ABSTRACTSon the endovascular database at 1, 3, and 12 months and annually there-
after. Changes in these measurements were calculated for each group.
Results: Palmaz stent-graft was used during 22 elective and 19 emergency
EVARs (17 elective and 10 emergency patients were included for analysis).
Throughout follow-up, the suprarenal diameter became greater in the
elective group (4.655.51mm vs. 2.24.13mm;p¼0.30) as were the top
neck (5.065.24mm vs. 4.66.02mm;p¼0.76) and bottom neck diameters
(5.946.53 vs. 3.114.26mm;p¼0.34). Aortic sac regression was higher in
emergency patients at 12 months (3.7121.03mm vs. 3.797.02mm;
p¼0.82) and at 24 months (1313.29mm vs. 4.369.61mm;p¼0.23). Open
re-intervention occurred in 20% of emergency patients for proximal type 1
endoleaks, with another 20% for stent-graft migrations. Re-intervention in
elective patients (18%) was for persistent type 2 endoleaks.
Conclusions: The complication rates, particularly in emergencies show
that Palmaz stenting provides only a short-term solution in EVAR. This
should inﬂuence patient selection as secondary procedures are more
likely.
0603: PERSISTENT SCIATIC ARTERY ANEURYSM: A PLEA FOR ATTEN-
TION AND PROPOSAL FOR MANAGEMENT
Nigel Day 1, Andrew Currie 1, Keith Jones 2. 1Kingston Hospital, London, UK;
2 St George's Hospital, London, UK.
Aim: This article reviewed published evidence on the identiﬁcation and
management of persistent sciatic artery aneurysms.
Methods: Systematic literature review was undertaken using Medline,
EMBASE and Cochrane Database of Systematic Reviews up to December
31st 2012. A free text search using “persistent sciatic artery”, “persistent
sciatic artery aneurysm”, “complete PSA” and “incomplete PSA” was per-
formed. All papers identiﬁed were screened and the search enhanced with
manual bibliography review.
Results: 49 relevant studies were identiﬁed. PSA has an incidence of
0.025%-0.04%. PSA aneurysms, though usually asymptomatic, may present
with a gluteal mass or distal embolization and ischaemia. Investigation is
most commonly performed by angiography, although non-invasive
methods show surgical planning advantages. Management is guided by
anatomical determination of the complete or incomplete forms. For the
complete forms, where the PSA supplies distal limb blood supply, this
entails exclusion of the aneurysm and vascular reconstruction with open
or endovascular techniques. Incomplete forms, where the PSA is present
with intact normal circulation, normally require simple aneurysmal
exclusion only.
Conclusion: Vascular specialists should be aware of this rare, often
asymptomatic vascular anomaly as it can complicate common vascular
emergencies. Timely surgical or endovascular interventions are vital due to
the high risk of aneurysmal dilatation.
0630: ASSESSING THE QUALITY OF ONLINE INFORMATION FOR PA-
TIENTS WITH CAROTID DISEASE
Cillian J. Keogh 1, Seamus M. McHugh 2, Mary Clarke-Moloney 2,
Paul E. Burke 2, Eamon G. Kavanagh 2, Pierce A. Grace 2,
Stewart R. Walsh 1. 1Graduate Entry Medical School, University of Limerick,
Limerick, Ireland; 2Department of Vascular Surgery, University Hospital
Limerick, Dooradoyle, Limerick, Ireland.
Aim: Controversy exists relating to carotid endarterectomy (CEA) versus
carotid artery stenting (CAS). We aimed to assess the quality of online
information relating to both.
Methods: The GoogleTM search engine was searched for “carotid endar-
terectomy” and “carotid stenting”. The ﬁrst 50 webpages returned were
assessed. The Gunning Fog Index (GFI) and Flesch Reading Ease Score
(FRES) were calculated to assess readability. The LIDA tool (Minervation
Ltd., Oxford, U.K.) was used to assess accessibility, usability and reliability.
Results: Regarding CEA, 20% (n¼10) of the webpages returned were from
peer reviewed sources with 34% (n¼17) posted by hospitals or health
services. Comparatively, for CAS, 40% (n¼20) were peer reviewed with 16%
(n¼8) posted by hospitals or health services. Regarding CEA, the GFI
and FRES indicated poor readability at 14.84 and 42.38 respectively. For
CAS web page assessment suggested further reduced readability with a GFI
of 15.91 and FRES score of 36.01. The LIDA score demonstrated that reli-
ability and accessibility of informationwas greater than usability for online
users.Conclusion: Websites providing information on carotid disease manage-
ment must be made more readable, reliable and usable. Online informa-
tion currently available to patients regarding CAS is signiﬁcantly more
difﬁcult to read and comprehend than CEA.
0653: REVIEW OF POST-OPERATIVE ANTICOAGULATION IN THE SURGI-
CAL MANAGEMENT OF ARTERIAL EMBOLIC DISEASE
Martha Nixon, Marcos Kostalas, Keith Gomes-Pinto, John Taylor,
David Williams. Northern Devon Healthcare NHS Trust, Barnstaple, UK.
Introduction: There is no guidance on post-operative anticoagulation af-
ter embolectomy. The purpose of this study was to review the use and
outcomes of low molecular weight heparin (LMWH) and unfractionated
heparin (UFH) following embolectomy.
Methods: Retrospective case review of patients undergoing embolectomy
from December 2009 - December 2012 was performed.
Results: 33 patients were included. 20 femoral, 5 brachial, 4 popliteal, 2
iliac and 2 graft embolectomies were performed. Anticoagulation prior to
surgery included heparin (n¼16, 48%), clexane (n¼4, 12%), or nothing
(n¼13, 39%). Intra-operatively heparin (n¼ 24, 73%) or nothing (n¼9, 27%)
was given. Post-operatively LMWH (n¼20, 61%), heparin (n¼9, 27%),
aspirin/clopidogrel (n¼3, 9%) or nothing (n¼1, 3%) was given. Patients
were discharged on warfarin (n¼21, 64%), aspirin (n¼5, 15%), clopidogrel
(n¼2, 3%), clexane (n¼3, 9%), rivaroxaban (n¼1, 3%) or nothing (n¼1, 3%).
The overall complication rate was 33% (including haematoma, wound
infection, amputation, claudication and death), 67% for those on heparin
post-operatively compared to 25% on clexane. Mortality was 30% with
average time to death of 9½ months.
Conclusion: This study has shown that clexane is a suitable and possibly
superior alternative to UFH. The authors have been surprised by the
mortality in this group of patients.
0681: ARE REFERRAL DELAYS CONTRIBUTING TO LIMB LOSS IN DIA-
BETIC PATIENTS?
Prashant Menon 2, Jenan Younis 2, M. Clarke 1, Alex Wee 1,
Emma Bingham1, Patrick Chong 2. 1Multidisciplinary Diabetic Foot Service
Frimley Park Hospital NHS Foundation Trust, Frimley, UK; 2Department of
Vascular Surgery Frimley Park Hospital NHS Foundation Trust, Frimley, UK.
A root cause analysis (RCA) was performed for major amputations (MA) in
diabetic patients to identify preventable causes for limb loss.
Data was collected retrospectively using HES codes for Diabetes and MA
(above knee/through knee/below knee) and analysed using the London
Diabetes Network RCA tool for MA.
20 diabetic patients underwentMA between 1st April 2010 and 31st March
2012. Median time from initial onset of symptoms (IOS) to any secondary
care review was 12 weeks while median time from IOS to diabetic foot
multidisciplinary team (DFMDT) review was 17 weeks. 6 patients (30%)
had no DFMDT clinic review before MA. 16 patients (80%) underwent in-
patient vascular imaging. Median interval from admission to vascular
imaging was 1 day (1-64). 10 patients (50%) underwent revascularisation
(Endovascular therapy n¼4 / Surgical bypass n¼3 / Endovascular Therapy
and Surgical Bypass n¼3) Median time from IOS to revascularisation was
70 days (2-1080) and median time from hospitalisation to revascularisa-
tion was 1 day (1-64). The 30-day post-MA mortality was 15%.
Our RCA highlights signiﬁcant delays in referral to the DFMDT in this
cohort with adverse limb salvage outcomes. The need to refer promptly to
the DFMDT should be stressed to carers in the community.
0781: PATIENT REPORTED OUTCOMES FOLLOWING CRITICAL
ISCHAEMIA MANAGEMENT IN THE REGIONAL VASCULAR CENTRE
Anna Kamocka, Ahmed Twaij, Oneet Sandher, Charlotte Ashton,
Jawaharlal Senaratne, Thomas Rix. Kent and Canterbury Hospital, East Kent
Hospitals Trust, Canterbury, Kent, UK.
Aims: Patient Reported Outcome Measures(PROMs) assess the health gain
after surgical intervention. Guided by existing PROMs assessments, we
designed a survey to review patient satisfaction following treatment of
critical limb ischaemia (CLI) at East Kent Hospitals Trust(EKHT).
Methods: All patients who underwent treatment for CLI between
November 2010 andMay 2011 were invited to ﬁll in an 11-question Patient
Satisfaction Survey, either by post or over the phone. Fisher's test was used
for statistical analysis.
